ReviewFrontiers in oncology2014
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma.
Hayley Patricia Ellis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ReviewFrontiers in oncology2014
Hayley Patricia Ellis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.